Cargando…
Vanoxerine kills mycobacteria through membrane depolarization and efflux inhibition
Mycobacterium tuberculosis is a deadly pathogen, currently the leading cause of death worldwide from a single infectious agent through tuberculosis infections. If the End TB 2030 strategy is to be achieved, additional drugs need to be identified and made available to supplement the current treatment...
Autores principales: | Kingdon, Alexander D. H., Meosa-John, Asti-Rochelle, Batt, Sarah M., Besra, Gurdyal S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909702/ https://www.ncbi.nlm.nih.gov/pubmed/36778873 http://dx.doi.org/10.3389/fmicb.2023.1112491 |
Ejemplares similares
-
The thick waxy coat of mycobacteria, a protective layer against antibiotics and the host's immune system
por: Batt, Sarah M., et al.
Publicado: (2020) -
Alkyltriphenylphosphonium turns naphthoquinoneimidazoles into potent membrane depolarizers against mycobacteria
por: Fridianto, Kevin Timothy, et al.
Publicado: (2022) -
Crystal structure of the TreS:Pep2 complex, initiating α-glucan synthesis in the GlgE pathway of mycobacteria
por: Kermani, Ali A., et al.
Publicado: (2019) -
Utilisation of the Prestwick Chemical Library to identify drugs that inhibit the growth of mycobacteria
por: Kanvatirth, Panchali, et al.
Publicado: (2019) -
Acceptor Substrate Discrimination in Phosphatidyl-myo-inositol Mannoside Synthesis: STRUCTURAL AND MUTATIONAL ANALYSIS OF MANNOSYLTRANSFERASE CORYNEBACTERIUM GLUTAMICUM PimB′
por: Batt, Sarah M., et al.
Publicado: (2010)